VMD: Report on the progress of the remediation of the status of controlled securities
Filed with HOSE · · 3 pages · English
Summary by 6ix AI
This filing is a report from Vimedimex Medi-Pharma JSC regarding the progress of remediation for its controlled securities status. The company has addressed issues related to its financial disclosures and has taken corrective measures to improve its stock status. It reports that the audited semi-annual financial statements for the current year have been submitted and received an unqualified opinion from auditors, resolving previous concerns. Additionally, the company has completed necessary corporate governance reports as required by regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/vmd-report-on-the-progress-of-the-remediation-of-the-status-of-controlled-securities
Vimedimex Medi-Pharma JSC on 6ix
Earlier from Vimedimex Medi-Pharma JSC
- VMD: Reminder of information disclosure
- VMD: Explanation of the differences in profit after tax in the first six months of 2026
- VMD: Changing from warning to supervision status
- VMD: Change in personnel
- VMD: Information on Authorization for information disclosure
Later from Vimedimex Medi-Pharma JSC
- VMD: Report on Corporate Governance for the first half of 2026
- VMD: Report on Corporate Governance 2025
- VMD: Annual Report 2025
- VMD: Information related to the 2025 cash dividend payment
Follow Vimedimex Medi-Pharma JSC into a list and get an email when it puts out news.
Follow Vimedimex Medi-Pharma JSC